Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Downgrades Emergent BioSolutions to Hold

Benchmark Downgrades Emergent BioSolutions to Hold

Benchmark analyst Robert Wasserman downgrades Emergent BioSolutions (NYSE:EBS) from Buy to Hold.

November 10, 2022

1 minute read

Benchmark analyst Robert Wasserman downgrades Emergent BioSolutions (NYSE:EBS) from Buy to Hold.

Assessing YETI Holdings: Insights From 5 Financial Analysts

April 5, 8:01 AM

Ratings for YETI Holdings (NYSE:YETI) were provided by 5 analysts in the past three months, showcasing a mix…

January 23, 7:59 AM

Barclays analyst Blayne Curtis maintains Silicon Laboratories (NASDAQ:SLAB) with a Underweight and raises the price target from $85 to $100.

November 21, 8:29 AM

Raymond James analyst Savanthi Syth maintains Copa Holdings (NYSE:CPA) with a Strong Buy and raises the price target from $117 to $125.

November 14, 12:00 PM

Fluor (NYSE:FLR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…